GlaxoSmithKline has announced a regulatory submission to the U.S. Food and Drug Administration for its type 2 diabetes drug called albigultide.
Read more
GSK Announces Regulatory Submission Of Its Type 2 Diabetes Drug Albigultide
Posted in Drugs